Jennison Associates
CVET

Jennison Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History

Jennison Associates’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-951,369
Closed -$19.9M – 645
2022
Q3 		$19.9M Buy
951,369
+14,416
+2% +$300K 0.02% 320
2022
Q2 		$19.4M Buy
936,953
+331,352
+55% +$5.9M 0.02% 311
2022
Q1 		$10.2M Buy
605,601
+17,784
+3% +$311K 0.01% 416
2021
Q4 		$11.7M Sell
587,817
-15,031
-2% -$283K 0.01% 429
2021
Q3 		$10.9M Sell
602,848
-76,764
-11% -$1.76M 0.01% 441
2021
Q2 		$18.4M Sell
679,612
-19,776
-3% -$553K 0.01% 380
2021
Q1 		$21M Buy
699,388
+278,391
+66% +$9.49M 0.02% 349
2020
Q4 		$12.1M Buy
+420,997
New +$11.4M 0.01% 390

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jennison Associates's CVET Position: Q4 2022 in Review

Jennison Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 951,369 shares — an estimated $19.9M sold.

Jennison Associates first reported a position in CVET in Q4 2020 and held it in 8 quarters. The position peaked at $21M in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Jennison Associates reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jennison Associates sold 951,369 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $19.9M.
  • Jennison Associates first reported a position in Covetrus, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Jennison Associates's Covetrus, Inc. Common Stock position peaked at $21M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Jennison Associates's 13F filing for Q4 2022, filed 9 Feb 2023.